Total Payments
$2,826
2024 Payments
$121.84
Companies
26
Transactions
117
Medicare Patients
1,529
Medicare Billing
$114,688
Payment Breakdown by Category
Food & Beverage$2,826 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,826 | 117 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $495.33 | 22 | $0 (2023) |
| ABBVIE INC. | $473.08 | 21 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $431.11 | 11 | $0 (2024) |
| Lilly USA, LLC | $205.82 | 11 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $199.33 | 1 | $0 (2021) |
| PFIZER INC. | $144.19 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $138.98 | 8 | $0 (2023) |
| Biohaven Pharmaceutical Holding Company Ltd. | $98.32 | 5 | $0 (2022) |
| Allergan, Inc. | $74.12 | 1 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $73.43 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $121.84 | 1 | AstraZeneca Pharmaceuticals LP ($121.84) |
| 2023 | $1,674 | 70 | ABBVIE INC. ($425.33) |
| 2022 | $830.55 | 45 | Novo Nordisk Inc ($167.54) |
| 2021 | $199.33 | 1 | E.R. Squibb & Sons, L.L.C. ($199.33) |
All Payment Transactions
117 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/21/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/02/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.32 | General |
| Category: Neuromodulation | ||||||
| 10/19/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $127.94 | General |
| Category: Respiratory | ||||||
| 10/10/2023 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: ETONOGESTREL | ||||||
| 07/19/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $118.37 | General |
| Category: Obesity | ||||||
| 07/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.18 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.86 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Diabetes | ||||||
| 06/22/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: VACCINES | ||||||
| 06/20/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: Diabetes | ||||||
| 06/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $26.41 | General |
| Category: DIABETES | ||||||
| 06/07/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.53 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Gastroenterology | ||||||
| 06/02/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $8.91 | General |
| 05/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 05/24/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: NEUROSCIENCE | ||||||
| 05/16/2023 | PFIZER INC. | PREVNAR 20 (Biological) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: VACCINES | ||||||
| 05/12/2023 | PFIZER INC. | COMIRNATY (Biological), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: VACCINES | ||||||
| 05/10/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $44.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/09/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Diabetes | ||||||
| 05/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.14 | General |
| Category: NEUROSCIENCE | ||||||
| 05/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Diabetes | ||||||
| 05/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 355 | 403 | $76,135 | $22,272 |
| 2022 | 5 | 252 | 272 | $69,572 | $19,886 |
| 2021 | 5 | 449 | 538 | $125,796 | $39,410 |
| 2020 | 6 | 473 | 573 | $125,594 | $33,119 |
Total Patients
1,529
Total Services
1,786
Medicare Billing
$114,688
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 114 | 122 | $35,756 | $9,570 | 26.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 128 | $23,996 | $7,162 | 29.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 21 | $8,925 | $2,414 | 27.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 32 | 33 | $2,607 | $1,659 | 63.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 25 | 52 | $3,068 | $843.44 | 27.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $616.00 | $320.87 | 52.1% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 15 | 15 | $915.00 | $256.13 | 28.0% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 21 | $252.00 | $46.20 | 18.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 122 | $28,426 | $8,165 | 28.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 64 | 67 | $20,904 | $7,162 | 34.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $8,950 | $2,212 | 24.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 30 | 30 | $4,740 | $1,284 | 27.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 28 | 28 | $6,552 | $1,064 | 16.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 197 | 253 | $58,949 | $18,631 | 31.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 59 | 86 | $26,832 | $9,300 | 34.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 109 | 109 | $25,506 | $6,402 | 25.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 73 | $11,534 | $4,049 | 35.1% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 15 | 17 | $2,975 | $1,029 | 34.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 237 | 329 | $76,657 | $20,068 | 26.2% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 128 | 128 | $29,952 | $6,998 | 23.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 24 | 30 | $9,282 | $2,807 | 30.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 49 | $7,742 | $2,139 | 27.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 19 | 21 | $1,497 | $772.25 | 51.6% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 16 | 16 | $464.00 | $335.81 | 72.4% |
About Shannon Mathis, NP-C
Shannon Mathis, NP-C is a Family healthcare provider based in Wilmington, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2019. The National Provider Identifier (NPI) number assigned to this provider is 1013472232.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Shannon Mathis, NP-C has received a total of $2,826 in payments from pharmaceutical and medical device companies, with $121.84 received in 2024. These payments were reported across 117 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($2,826).
As a Medicare-enrolled provider, Mathis has provided services to 1,529 Medicare beneficiaries, totaling 1,786 services with total Medicare billing of $114,688. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Wilmington, NC
- Active Since 02/01/2019
- Last Updated 03/17/2025
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1013472232
Products in Payments
- VRAYLAR (Drug) $353.78
- FARXIGA (Drug) $303.17
- Wegovy (Drug) $200.24
- ZEPOSIA (Drug) $199.33
- MOUNJARO (Drug) $178.76
- ENTRESTO (Drug) $138.98
- BREZTRI (Drug) $127.94
- JARDIANCE (Drug) $100.49
- NURTEC ODT (Drug) $98.32
- COMIRNATY (Biological) $87.17
- Ozempic (Drug) $59.49
- QULIPTA (Drug) $51.29
- Kerendia (Drug) $45.68
- UBRELVY (Drug) $44.65
- TOUJEO (Biological) $44.38
- NOCDURNA (Drug) $42.78
- PREVNAR 20 (Biological) $41.98
- Cologuard Collection Kit (Device) $39.98
- STEGLATRO (Drug) $35.94
- Otezla (Drug) $30.56
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Wilmington
Mrs. Teresa Doss, Fnp, FNP
Family — Payments: $136,813
Family $136,813
Courtney Wilson, Fnp, FNP
Family — Payments: $80,683
Family $80,683
Dr. Tracy Estes, Phd, Dnp, Rn, Fnp-Bc, PHD, DNP, RN, FNP-BC
Family — Payments: $44,994
Family $44,994
Leshonda Wallace, Fnp, FNP
Family — Payments: $26,198
Family $26,198
Kelly Glisson, Np, NP
Family — Payments: $25,965
Family $25,965
Elizabeth Sharp-Asiyo, Fnp, FNP
Family — Payments: $12,979
Family $12,979